Constellation Software’s growth plan is failing, Michael Sprung says

MICHAEL SPRUNG

Has Constellation Software’s (Constellation Software Stock Quote, Chart, News: TSX:CSU) magic run come to an end?

One of the shining stars of the Canadian tech sector over the past decade, the company’s growth-by-acquisition formula appears to be wearing around the edges, says investment manager Michael Sprung, who doesn’t see enough organic growth from the company.

Toronto-based Constellation Software has made a name for itself in acquiring tech startups (they currently own over 250) at early stages and holding onto them while they mature into money-making enterprises.

That approach has been successful, for the most part, says Sprung, President of Sprung Investment Management, but the company’s core business doesn’t deserve its current valuation.

“It has by and large been a growth by acquisition story. They have done exceedingly well at it and that’s been reflected in the stock price,” Sprung told BNN yesterday.

“It’s one of these stocks that, as a value investor, I look at the multiple they put on Constellation Software, and to me, it’s valued at a continuation of a very, very high rate of growth. It could be vulnerable to a setback should that [growth] not continue to increase going forward.”

From 2010 onwards, Constellation’s share price has shot up from $36.00 to a high reached on March 21 of $915.00. Since then, the stock has dropped to the mid-$880.00 range, dipping down into the $940.00 range last week. The company plans on releasing its first quarter of 2018 financial results on April 25.

Constellation is facing increasing pressure from private equity competitors who are reportedly outbidding the company on takeover targets as of late.

“On the other side of it, organic growth has not been as high as what people were expecting,” says Sprung, “and I think that one thing that could be a catalyst to see [the stock price] move up would be better numbers on the organic growth side, aside from the acquisition part of it.”

“[Growth by acquisition] really depends on companies being able to finance that growth through borrowing, whether that’s debt or equity. Eventually, that often comes to an end,” he says.

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Tagged with: csu
Jayson MacLean

Jayson is a writer, researcher and educator with a PhD in political philosophy from the University of Ottawa. His interests range from bioethics and innovations in the health sciences to governance, social justice and the history of ideas.

Recent Posts

Is Peloton Stock a Buy? (May, 2024)

Following news of a restructuring, Roth MKM analyst George Kelly has chopped his price target on Peloton (Peloton Stock Quote,… [Read More]

8 hours ago

Is Ascend Wellness stock a buy?

Ahead of the company's first quarter results, Beacon analyst Russell Stanley thinks Ascend Wellness (Ascend Wellness Stock Quote, Chart, News,… [Read More]

8 hours ago

Paradigm chops price target on Snipp Interactive

Following the company's fourth quarter results, Paradigm Capital analyst Daniel Rosenberg has cut his price target on Snipp Interactive (Snipp… [Read More]

9 hours ago

It’s time to buy cannabis stocks, this analyst says

A major development came down the pipe this week at the U.S. Drug Enforcement Agency has reportedly decided to reschedule… [Read More]

23 hours ago

Is Generac stock a buy?

Following the company's first quarter results, Roth MKM analyst Chip Moore remains neutral on Generac Holdings (Generac Holdings Stock Quote,… [Read More]

1 day ago

Bombardier is a buy, Desjardins says (May, 2024)

The stock has climbed slowly but surely since last October. But is there still money to be made on Bombardier?… [Read More]

1 day ago